PharmDr. Ondřej Zendulka, Ph.D.


Office: bud. A19/323b
Kamenice 753/5
625 00 Brno

Show on the map

Mobile phone: +420 777 130 111
Phone: +420 549 49 3971
E‑mail:
Qualifications

Ongoing procedure

Habilitation procedures
Applicant's name at procedure initiation PharmDr. Ondřej Zendulka, Ph.D.
Applicant's workplace at procedure initiation Faculty of Medicine
Procedure field Medical Pharmacology
Faculty implementing procedure Faculty of Medicine
Procedure status appointment recommended by habilitation board
Procedure initiation date 13 Dec 2018
Habilitation thesis (publicly available part) The role of cytochrome P450 in drug safety and efficacy
Habilitation thesis reviewers prof. MUDr. Stanislav Mičuda, Ph.D. (Ústav farmakologie LF UK)
prof. Wladyslawa Daniel, PhD (Maj Institute of Pharmacology)
prof. PharmDr. Ján Klimas, PhD. (Farmaceutická fakulta UK Bratislava, SR)
Reviewers' thesis reports Report 1 | Report 2 | Report 3
Public lecture 21 Jun 2019 | Lecture Evaluation
habilitation board
Chair prof. PharmDr. Petr Babula, Ph.D. (Faculty of Medicine MU)
Members doc. MUDr. Regina Demlová, Ph.D. (Faculty of Medicine MU)
prof. PharmDr. Daniela Ježová, DrSc. (Ústav experimentálnej endokrinológie SAV)
prof. RNDr. Pavel Anzenbacher, DrSc. (Lékařská fakulta UP Olomouc)
prof. Dr. Julia Carolin Stingl (- Federal Institute for Drugs and Medical Devices, University Bonn Medical School)
Board's position Board'S Position